BioVista was formed in 1998 as a limited liability company
under Swiss law. The founders are
Ms. Mysicka is primarily responsible for Research & Applications
in the area of IVIVC. She has
accumulated extensive experience in the development, verification
and application of these
correlations, in setting in vitro dissolution specifications
and in the pharmacokinetic assessment
of solid dosage forms during her 20 years with Ciba and Novartis.
Harald Rettig, Ph. D
(Retired since 1.1.2010)
Mr. Rettig is responsible for BioVista's business development.
Prior to co-founding the company, he
held numerous positions in Ciba's Pharmaceuticals Division,
lastly as world-wide Head for
Pharmaceutical and Analytical Development. He has worked in
several countries, including the USA.
His particular expertise is in the area of biopharmaceutics
and their regulatory requirements.